THE RED HOUSE GROUP
THE RED HOUSE SURGERY, 124 WATLING STREET, RADLETT
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 7 | 10 | 70.0% | |
| HF 4 | 2011 | 10 | 13 | 76.9% | |
| HF 4 | 2012 | 9 | 15 | 60.0% | |
| HF 4 | 2013 | 16 | 18 | 88.9% | |
| HF004 | 2014 | 2 | 2 | 100.0% | |
| HF004 | 2015 | 3 | 3 | 100.0% | |
| HF004 | 2016 | 2 | 2 | 100.0% | |
| HF004 | 2017 | 5 | 5 | 100.0% | |
| HF004 | 2018 | 6 | 6 | 100.0% | |
| HF004 | 2019 | 70 | 79 | 88.6% | |
| HF004 | 2020 | 51 | 56 | 91.1% | |
| HF006 | 2021 | 58 | 67 | 86.6% | |
| HF006 | 2022 | 60 | 62 | 96.8% | |
| HF006 | 2023 | 55 | 58 | 94.8% |
